🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Omar Alhalabi

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-9658-2206

Also affiliated with University of Buckingham

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma”.

Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma

The Journal of Urology(2024)10.1097/ju.0000000000003928
N/A
0.411DataRank · unranked
8 citations

Mehrad Adibi, Amishi Y. Shah, Omar Alhalabi, Paul G. Corn, Charles C. Guo +8 more

Molecular profile of micropapillary urothelial carcinoma of the urinary bladder: An analysis of 99 cases by next-generation sequencing

Human Pathology(2025)10.1016/j.humpath.2025.105812
N/A
0.241DataRank · unranked
4 citations

Lan Zheng, Jianping Zhao, Yishan Wang, Hui Chen, Sinchita Roy‐Chowdhuri +9 more

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma

Cancer Medicine(2025)10.1002/cam4.70280
N/A
0.212DataRank · unranked
3 citations

Mohamed A. Gouda, Denái R. Milton, Hassan Ahmed Momin, Bülent Yılmaz, Bettzy Stephen +16 more

Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies

npj Precision Oncology(2023)10.1038/s41698-023-00369-w
N/A
0DataRank · unranked
7 citations

Roman Groisberg, Ralph Zinner, Andrew W. Hahn, Aung Naing, Shizhen Zhang +16 more

Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer

Endocrinology(2023)10.1210/endocr/bqad071
N/A
0DataRank · unranked
7 citations

Eleonora Dondossola, Kaitlin J. Basham, Nathaniel R. Wilson, Omar Alhalabi, Jianjun Gao +7 more

Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0751
N/A
0DataRank · unranked
11 citations

Andrew W. Hahn, Pavlos Msaouel, Alexander Andreev-Drakhlin, Funda Meric‐Bernstam, Aung Naing +17 more

Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder

ESMO Open(2024)10.1016/j.esmoop.2024.103964
N/A
0DataRank · unranked
7 citations

Andrew M. Fang, Mohammad Jad Moussa, Hyunsoo Hwang, Nathaniel R. Wilson, Matthew T. Campbell +9 more

Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit

Cancer Cell(2025)10.1016/j.ccell.2025.03.005
N/A
0DataRank · unranked
12 citations

Omar Alhalabi, Sangeeta Goswami, Padmanee Sharma, Kristen E. Pauken

Plasmacytoid urothelial carcinoma of the urinary bladder–A clinicopathological and molecular analysis of 52 cases

Human Pathology(2024)10.1016/j.humpath.2024.04.012
N/A
0DataRank · unranked
8 citations

Hui Chen, Jianping Zhao, Sinchita Roy‐Chowdhuri, Ashish M. Kamat, Omar Alhalabi +6 more

Managing Cancer Care during the COVID-19 Pandemic and Beyond

Trends in cancer(2020)10.1016/j.trecan.2020.04.005
N/A
0DataRank · unranked
36 citations

Vivek Subbiah, Omar Alhalabi

Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.07.004
N/A
0DataRank · unranked
2 citations

Andrew W. Hahn, Pavlos Msaouel, Funda Meric‐Bernstam, Nathaniel R. Wilson, Aung Naing +18 more